AbbVie Inc.
ABBV
$218.10
$3.601.68%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 695.00M | 1.82B | 186.00M | 938.00M | 1.29B |
| Total Depreciation and Amortization | 1.94B | 1.99B | 2.06B | 2.05B | 2.04B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.12B | 1.89B | 3.52B | 2.73B | 890.00M |
| Change in Net Operating Assets | -1.92B | -473.00M | 1.25B | -562.00M | -2.58B |
| Cash from Operations | 3.83B | 5.22B | 7.02B | 5.15B | 1.64B |
| Capital Expenditure | -265.00M | -329.00M | -381.00M | -269.00M | -235.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -266.00M | -1.16B | -2.80B | -940.00M | -538.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.00M | 27.00M | -81.00M | 28.00M | 38.00M |
| Cash from Investing | -574.00M | -1.46B | -3.26B | -1.18B | -735.00M |
| Total Debt Issued | 7.99B | -500.00M | 241.00M | 3.96B | 5.59B |
| Total Debt Repaid | -2.50B | -799.00M | -2.02B | -3.75B | -3.03B |
| Issuance of Common Stock | -- | 48.00M | 63.00M | 5.00M | -- |
| Repurchase of Common Stock | -1.49B | -3.00M | -4.00M | -12.00M | -961.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.09B | -2.91B | -2.91B | -2.91B | -2.93B |
| Other Financing Activities | 2.00M | -1.00M | 37.00M | -2.00M | 67.00M |
| Cash from Financing | 919.00M | -4.17B | -4.59B | -2.71B | -1.26B |
| Foreign Exchange rate Adjustments | -12.00M | 11.00M | -8.00M | 30.00M | 9.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.16B | -400.00M | -838.00M | 1.29B | -349.00M |